| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $38.6M | +2386.0% |
| Cost of Revenue | $32.4M | +5502.4% |
| Gross Profit | $6.2M | +535.3% |
| R&D Expense | $42.5M | +69.5% |
| SG&A Expense | $110.0M | +126.4% |
| Operating Income | -$103.8M | -1986.6% |
| Pre-tax Income | -$206.7M | -5647.1% |
| Income Tax | $217K | -58.0% |
| Net Income | -$206.9M | -4929.8% |
| EPS (Basic) | -$1.98 | +43.4% |
| EPS (Diluted) | -$1.98 | +43.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.8M | — |
| Inventory | $10.1M | +18.3% |
| Current Assets | $96.6M | — |
| Total Assets | $102.2M | +111.5% |
| Current Liabilities | $43.4M | +209.5% |
| Total Liabilities | $63.2M | +162.5% |
| Stockholders' Equity | $39.0M | +266.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$73.8M | -2561.6% |
| Capital Expenditures | $788K | -12.6% |
| Investing Cash Flow | -$788K | -143.8% |
| Financing Cash Flow | $70.1M | +7809.8% |
| Free Cash Flow | -$74.5M | -1929.4% |